6-methyl-2-propan-2-yl-1H-pyrimidin-4-one

We are 6-methyl-2-propan-2-yl-1H-pyrimidin-4-one CAS:2814-20-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 2814-20-2
Product Name: 6-methyl-2-propan-2-yl-1H-pyrimidin-4-one
Other Name:
6-methyl-2-propan-2-yl-1H-pyrimidin-4-one
2-Isopropyl-6-methyl-4-hydroxypyrimidine
2-Isopropyl-6-methylpyrimidin-4(3H)-one
6-hydroxy-2-isopropyl-4-methylpyrimidine
6-methyl-2-(propan-2-yl)pyrimidin-4(1H)-one
4(1H)-Pyrimidinone,6-methyl-2-(1-methylethyl)
4-hydroxy-2-isopropyl-6-methyl-pyrimidine
6-methyl-2-(propan-2-yl)pyrimidin-4-ol
6-methyl-2-(1-methylethyl)pyrimidin-4(1H)-one
2-isopropyl-4-hydroxy-6-methylpyrimidine
2-Isopropyl-6-methyl-4(1H)-pyrimidinone
2-Isopropyl-6-methylpyrimidin-4-ol
2-Isopropyl-4-methyl-6-hydroxypyrimidine
2-Isopropyl-6-methyl-4-pyrimidinol
 
Density: 1.1±0.1 g/cm3
Boiling Point: 244.3±20.0 °C at 760 mmHg
Melting Point: 172-175 °C(lit.)
Molecular Formula: C8H12N2O
Molecular Weight: 152.194
Flash Point: 101.6±21.8 °C
Exact Mass: 152.094955
PSA: 46.01000
LogP: 0.50
Vapour Pressure: 0.0±0.5 mmHg at 25°C
Index of Refraction: 1.528
 
Specification
Appearance: White Crystal Solid
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Diazinon CAS: 333-41-5.
Be used as pesticide intermediate, mainly used in the synthesis of the insecticide Diazinon.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

6-methyl-2-propan-2-yl-1H-pyrimidin-4-one


Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.2-Amino-3,5-dichloropyridine CAS:4214-74-8 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.4101-68-2 Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.(3S)-3-(4-Nitro-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione CAS:827026-45-9 In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.

Related Products
Product Name
1,3-Bis(isocyanatomethyl)benzene View Details
3-Nitro-4-hydroxyquinoline View Details
D-histidine View Details
L-Arginine L-aspartate manufacturer (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan manufacturer 11α-Hydroxy Canrenone manufacturer Sermorelin manufacturer 2,4-Dichloropyrido[2,3-d]pyrimidine manufacturer